RNA Sequencing Services Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The RNA Sequencing Services Market By 2029?

The rna sequencing services market has experienced rapid expansion in recent years. Its valuation is projected to increase from $3.58 billion in 2024 to $3.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.4%. This historical growth can be attributed to factors such as the increasing demand for personalized medicine, progress in bioinformatics tools, a stronger focus on drug discovery and development, the rising integration of RNA sequencing into agricultural research, and its broadening applications in clinical diagnostics.

The rna sequencing services market size is projected to experience swift expansion in the upcoming years. This market is anticipated to reach $5.92 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.4%. Several factors are expected to drive this growth during the forecast period, including the advent of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning into data analysis, increasing investigation into non-coding RNA biomarkers, a surging need for transcriptomic analysis within immunotherapy research, and escalating partnerships between academic institutions and industries in genomic studies. Key trends foreseen in this period encompass the adoption of long-read sequencing, the use of cloud-based analysis platforms, an increasing requirement for RNA splicing analysis, and the integration of multi-omics data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

Which Major Market Drivers Are Shaping The Future Of The RNA Sequencing Services Market?

The RNA sequencing services market is significantly growing, largely driven by the increasing demand for personalized medicine. Personalized medicine refers to adapting medical treatment to individual traits, such as genetics or lifestyle, to maximize effectiveness and reduce negative effects. This rising demand for personalized medicine is propelled by its promise of more effective treatments, progress in genomics, the growing complexity of diseases, and regulatory support. RNA sequencing services are instrumental in identifying disease subtypes, discovering biomarkers, pinpointing therapeutic targets, predicting therapy responses, and monitoring disease progression and treatment outcomes. Personalized medicine techniques employ RNA sequencing technologies to deliver individualized and effective medicines that target the unique molecular characteristics of patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA (Food and Drug Administration) approved 16 novel personalized therapies for patients with rare diseases in 2023, an increase from six in 2022. The personalized treatments newly approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the escalating demand for personalized medicine is fueling the growth of the RNA sequencing services market going forward.

Which Key Segments Fueling The RNA Sequencing Services Market?

The rna sequencing servicesmarket covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA); Transfer RNA (tRNA); Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods; Other Sequencing Methods

3) By Application Area: Research Purposes; Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing; RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling; TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling; lncRNA Sequencing

What Long-Term Trends Will Shape The Future Growth Of The RNA Sequencing Services Industry?

Major companies operating in the RNA sequencing services market are increasingly focusing on automation to minimize potential human error, particularly with next-generation sequencing (NGS) assays, aiming to significantly enhance the efficiency and accuracy of data generation and analysis processes. The RNA next-generation sequencing (RNA-seq) assay serves as a powerful instrument in molecular biology and genomics for analyzing the transcriptome of biological samples. For instance, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, known as Tempus xR. This innovative assay is specifically designed for solid tumors, delivering a comprehensive analysis of the entire transcriptome, which highlights clinically significant fusions in more than 100 targeted genes, alongside altered splicing for MET Exon 14 and EGFRvIII. Recognizing the critical nature of RNA sequencing data, Tempus has traditionally included both RNA and DNA sequencing within its standard xT broad-panel assay. Presently, clients have the flexibility to order each test either separately or at the same time, with the option to enhance xR with certain Tempus algorithmic tests. This offering is tailored to physicians with a specific interest in RNA fusions or altered splicing, as well as to providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis for their existing samples.

Which Major Firms Are Strengthening Their Position In The RNA Sequencing Services Industry?

Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The RNA Sequencing Services Market Report:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2025, By The Business Research Company

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795